Direct extraction of Sabin poliovirus genomes from human fecal samples using a guanidine thiocyanate extraction method

Journal of Virological Methods

Volumn 110, Issue 2, 2003, Pages 193-200

  Old, Matthew O ^a   Martinez, Claudia V ^a   Kwock, Douglas ^a   Garcia, Joaquin ^a   Martin, Gladys ^a   Chan, Christina ^a   Maldonado, Yvonne A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Enteroviruses; Fecal specimens; Guanidine thiocyanate extraction; Rapid diagnosis; Sabin oral poliovirus vaccine type 3; Tissue cultivation

Indexed keywords

GUANIDINE THIOCYANATE; ORAL POLIOMYELITIS VACCINE; THIOCYANIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VIRUS RNA;

ACCURACY; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COST; DILUTION; ENTEROVIRUS; EXTRACTION; FECES ANALYSIS; GENE SEQUENCE; GENETIC ANALYSIS; GENOME ANALYSIS; IN VIVO STUDY; NONHUMAN; POINT MUTATION; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SABIN POLIOVIRUS; SEQUENCE ANALYSIS; TISSUE CULTURE; VIRUS TYPING;

ENTEROVIRUS; HUMAN POLIOVIRUS 3; POLIOVIRUS;

EID: 0038730775     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(03)00133-2     Document Type: Article

References (50)

1. American Academy of Family Physicians, 1999. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP) and American Academy of Family Physicians (AAFP), Am. Fam. Physician 59, 2565-2574.
2. American Academy of Pediatrics, Committee on Infectious Diseases, 1999. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP), Pediatrics 103, 1064-1077.
3. Bell E.J., Cosgrove B.P. Routine enterovirus diagnosis in a human rhabdomyosarcoma cell line. Bull. WHO. 58:1980;423-428.
4. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:(3):1990;495-503.
5. Boom R., Sol C., Weel J., Lettinga K., Gerrits Y., van Breda A., Wertheim-Van Dillen P. Detection and quantitation of human cytomegalovirus DNA in feces. J. Virol. Meth. 84:2000;1-14.
6. Buonagurio D.A., Coleman J.W., Patibandla S.A., Prabhakar B.S., Tatem J.M. Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccines by a sensitive reverse transcription-PCR method. J. Clin. Microbiol. 37:(2):1999;283-289.
7. Carter M.J., Milton I.D. An inexpensive and simple method for DNA purifications on silica particles. Nucleic Acids Res. 21:(4):1993;1044.
8. Centers for Disease Control and Prevention (CDC), 1999. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP), MMWR, 48(No.RR-5), 1-15.
9. Centers for Disease Control (CDC), 2001 Progress toward global poliomyelitis eradication, 2000. MMWR, 50, 320-313.
10. Cherkasova E.A., Korotkova E.A., Yakovenko M.L., Ivanova O.E., Eremeeva T.P., Chumakov K.M., Agol V.I. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J. Virol. 76:(13):2002;6791-6799.
11. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
12. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
13. Chonmaitree T., Ford C., Sanders C., Lucia H.L. Comparison of cell cultures for rapid isolation of enteroviruses. J. Clin. Microbiol. 26:1988;2576-2580.
14. Chumakov K.M., Dragunscky E.M., Norwood L.P., Douthitt M.P., Ran Y., Taffs R.E., Ridge J., Levenbook I.S. Consistent selection of mutations in the 5′-untranslated region of oral poliovirus vaccine upon passaging in vitro. J. Med. Virol. 42:1994;79-85.
15. Ciulla T.A., Sklar R.M., Hauser S.L. A simple method for DNA purification from peripheral blood. Anal. Biochem. 174:1988;485-488.
16. Cone R.W., Hobson A.C., Huang M.L. Coamplified positive control detects inhibition of polymerase chain reactions. J. Clin. Microbiol. 30:1992;3185-3189.
17. Cox R.A. The use of guanidinium chloride in the isolation of nucleic acids. Methods Enzymol. 12B:1968;120-129.
18. Da Silva, E., 1998. Molecular characterization of vaccine-derived poliovirus isolates found in Brazil after eradication of the indigenous wild polioviruses. Abstract presented at meeting on the Scientific Basis for Stopping Polio Immunization, Geneva, 23-25 March 1998.
19. Dagan R., Menegus M.A. A combination of four cell types for rapid detection of enteroviruses in clinical samples. J. Med. Virol. 19:1986;219-228.
20. Dahling D.R., Wright B.A. Optimization of the BGM cell line culture and viral assay procedures for monitoring viruses in the environment. Appl. Environ. Microbiol. 51:1986;790-812.
21. De L., Nottay B., Yang C.F., Holloway B.P., Pallansch M., Kew O. Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J. Clin. Microbiol. 33:1995;562-571.
22. Dunn G., Begg N.T., Cammack N., Minor P.D. Virus excretion and mutation by infants following primary vaccination with live oral polio vaccine from two sources. J. Med. Virol. 32:1990;92-95.
23. Glimåker M., Abebe A., Johansson B., Ehrnst A., Olcén P., Strannegård O. Detection of enteroviral RNA by polymerase chain reaction in fecal samples from patients with aseptic meningitis. J. Med. Virol. 38:1992;54-61.
24. Hale A.D., Green J., Brown D.W. Comparison of four RNA extraction methods for the detection of small round structured viruses in fecal specimens. J. Virol. Meth. 57:(2):1996;195-201.
25. Handt O., Höss M., Krings M., Pääbo S. Ancient DNA: methodological challenges. Experentia. 50:1994;524-529.
26. Johnston S.L.G., Siegel C.S. Presumptive identification of enteroviruses with RD, Hep-2, and RMK cell lines. J. Clin. Microbiol. 28:1990;1049-1050.
27. Kew O.M., Nottay B.K., Hatch M.H., Nakano J.H., Obijeski J.F. Multiple genetic changes can occur in oral polio vaccines upon replication in humans. J. Gen. Virol. 56:1981;337-347.
28. Kimman T.G., Koopmans M.P.G., Van de Avoort H.G.A.M. Ending polio immunization: when and how are we sure that the needle is out of the haystack. Vaccine. 17:1999;624-627.
29. Lipson S.M., Walderman R., Costello P., Szabo K. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J. Clin. Microbiol. 26:1988;1298-1303.
30. Maldonado Y.A., Peña-Cruz V., Sanchez M., Cantwell M., Logan L., Blandón S., Matsui S., Millan-Velasco F., Valdespino J.L., Sepulveda J. Host and viral factors affecting the decreased immunogenicity of Sabin type 3 vaccination after administration of trivalent oral polio vaccine (OPV) to rural Mayan children. J. Infect. Dis. 175:1997;545-553.
31. Maldonado Y., Cantwell M., Old M., Hill D., Sanchez M.L., Logan L., Millan-Velasco F., Valdespino J.L., Sepulveda J., Matsui S. Population-based prevalence of symptomatic and asymptomatic astrovirus infection in rural Mayan infants. J. Infect. Dis. 178:1998;334-339.
32. Mas Lago P., Caceres V., Galindo M., Gary H. Jr, Valcarcel M., Barrios J., Sarmiento L., Avalos I., Bravo J., Palomera R., Bello M., Sutter R., Pallansch M., Quadros C. Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int. J. Epidemiol. 30:2001;1029-1034.
33. Melnick J.L. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and newer Enteroviruses. Fields B.N., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., Roizman B., Straus S.E. Fields Virology. third ed: 1996;655-712 Lippincott-Raven Publishers, Philadelphia.
34. Norcott J.P., Green J., Lewis D., Estes M.K., Barlow K.L., Brown D.W. Genomic diversity of small round structured viruses in the United Kingdom. J. Med. Virol. 44:1994;280-286.
35. Ogilvie M. Molecular techniques should not now replace cell culture in diagnostic virology laboratories. Rev. Med. Virol. 11:2001;351-354.
36. Olive D.M., Al-Mufti S., Al-Mulla W., Khan M.A., Pasca A., Stanway G., Al-Nakib W. Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J. Gen. Virol. 71:1990;2141-2147.
37. Pozo F., Casas I., Tenorio A., Trallero G., Echevarria J.M. Evaluation of a commercially available reverse transcription-PCR assay for diagnosis of enteroviral infection in archival and prospectively collected cerebrospinal fluid specimens. J. Clin. Microbiol. 36:(6):1998;1741-1745.
38. Salahuddin S.Z., Ablashi V., Markham P.D., Josephs S.F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B., et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 234:1986;596-601.
39. Schafer R.W., Levee D.J., Einters M.A., Richmond K.L., Huang D., Merigan T.C. Comparison of QIAamp HCV kit spin columns, silica beads, and phenol-chloroform for recovering human immunodeficiency virus type 1 RNA from plasma. J. Clin. Microbiol. 35:(2):1997;520-522.
40. Schmidt N. Chapter 3: cell culture procedures for diagnostic virology. Schmidt N.J., Emmons R.W. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections. sixth ed. 1989;51-100 American Public Health Association, Washington, DC.
41. Schwab K.J., Estes M.K., Neill F.H., Atmar R.L. Use of heat release and internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J. Clin. Microbiol. 35:(2):1997;511-514.
42. Stanway G., Cann A.J., Hauptmann R., Hughes P., Clarke L.D., Mountford R.C., Minor P.D., Schild G.C., Almond J.W. The nucleotide sequence of poliovirus type 3 Leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res. 25:(11-16):1983;5629-5643.
43. Strebel P.M., Sutter R.W., Cochi S.L., Biellik R.J., Brink E.W., Kew O.M., Pallansch M.A., Orenstein W.A., Hinman A.R. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin. Infect. Dis. 14:1992;568-579.
44. Swennen B., Levy J. Oral poliomyelitis vaccine: time to change. Vaccine. 19:2001;2262-2267.
45. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., Cox N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 279:1998;393-396.
46. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., Osterhaus A.D. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:(6):2001;719-724.
47. Wattigney W., Mootrey G., Braun M., Chen R. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Pediatrics. 107:(5):2001;1-7.
48. Wilde J., Eiden J., Yolken R. Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions. J. Clin. Microbiol. 26:(6):1990;1300-1307.
49. Wilson I.G. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol. 63:1997;3741-3751.
50. Yang C.F., De L., Holloway B.P., Pallansch M.A., Kew O.M. Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res. 20:1991;159-179.